References
- Davis LL, Frazier E, Husain MM, Warden D, Trivedi M, Fava M, Cassano P, McGrath PJ, Balasubramani GK, Wisniewski SR, et al. Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR* D cohort. Am J Addict. 2006;15(4):278–85. doi:https://doi.org/10.1080/10550490600754317.
- Pettinati HM, O’Brien CP, Dundon WD. Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry. 2013;170(1):23–30. doi:https://doi.org/10.1176/appi.ajp.2012.12010112.
- Davis L, Uezato A, Newell JM, Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry. 2008;21(1):14–8. doi:https://doi.org/10.1097/YCO.0b013e3282f32408.
- Schuckit MA, Smith TL, Kalmijn J. Relationships among independent major depressions, alcohol use, and other substance use and related problems over 30 years in 397 families. J Stud Alcohol Drugs. 2013;74(2):271–9. doi:https://doi.org/10.15288/jsad.2013.74.271.
- Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. J Am Med Assoc. 2004;291(15):1887–96. doi:https://doi.org/10.1001/jama.291.15.1887.
- Brown S, Schuckit M. Changes in depression among abstinent alcoholics. J Stud Alcohol. 1988;49(5):412–7. doi:https://doi.org/10.15288/jsa.1988.49.412.
- Brown SA, Inaba RK, Gillin JC, Schuckit MA. Alcoholism and affective disorder: clinical course of depressive symptoms. Am J Psychiatry. 1995;152:45–52.
- Maremmani A, Pacini M, Maremmani I. What we have learned from the methadone maintenance treatment of dual disorder heroin use disorder patients. Int J Environ Res Public Health. 2019;16(3):447. doi:https://doi.org/10.3390/ijerph16030447.
- Strain EC, Stitzer ML, Bigelow GE. Early treatment time course of depressive symptoms in opiate addicts. J Nerv Ment Dis. 1991;179(4):215–21.
- Basu D, Aggarwal M, Das PP, Mattoo SK, Kulhara P, Varma VK. Changing pattern of substance abuse in patients attending a de-addiction centre in north India (1978–2008). Indian J Med Res. 2012;135(6):830–6.
- World Health Organization. 1992. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.
- First MB, France A, Pincus HA. 2004. Diagnostic and statistical manual of mental disorders Text Revision (DSM-IV-TR) guidebook. Washington, DC: American Psychiatric Publishing.
- SPSS Inc. Released. 2007. SPSS for Windows, Version 16.0. Chicago, IL: SPSS Inc.
- Sheehan DV, Janavs J, Baker R, Harnett-Sheehan K, Knapp E, Sheehan M, et al. MINI-Mini International neuropsychiatric interview- English version 5.0.0-DSM-IV. J Clin Psychiatry. 1998;59:34–57.
- Hasin DS, Trautman KD, Miele GM, Samet S. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry. 1996;153(9):1195–201.
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. doi:https://doi.org/10.1136/jnnp.23.1.56.
- Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77–100. doi:https://doi.org/10.1016/0272-7358(88)90050-5.
- Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–5. doi:https://doi.org/10.1111/j.2044-8341.1959.tb00467.x.
- Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of Alcohol Withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84(11):1353–7. doi:https://doi.org/10.1111/j.1360-0443.1989.tb00737.x.
- Wesson D, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253–9. doi:https://doi.org/10.1080/02791072.2003.10400007.
- Sutherland G, Edwards G, Taylor C, Phillips G, Gossop M, Brady R. The measurement of opiate dependence. Addiction. 1986;81(4):485–94. doi:https://doi.org/10.1111/j.1360-0443.1986.tb00360.x.
- Stockwell T, Sitharthan T, McGrath D, Lang E. The measurement of alcohol dependence and impaired control in community samples. Addiction. 1994;89(2):167–74. doi:https://doi.org/10.1111/j.1360-0443.1994.tb00875.x.
- Drobes DJ, Thomas SE. Assessing craving for alcohol. Alcohol Res Health. 1999;23(3):179–86.
- Franken IH, Hendriks VM, van den Brink W. Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict Behav. 2002;27(5):675–85. doi:https://doi.org/10.1016/s0306-4603(01)00201-5.
- Broadhead WE, Gehlbach SH, De Gruy FV, Kaplan BH. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care. 1988;26(7):709–23. doi:https://doi.org/10.1097/00005650-198807000-00006.
- Maxwell ME. 1992. Family Interview for Genetic Studies (FIGS): a manual for FIGS. Bethesda, MD: Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health.
- Von Korff M, Shortreed SM, LeResche L, Saunders K, Thielke S, Thakral M, Rosenberg D, Turner JA. A longitudinal study of depression among middle-aged and senior patients initiating chronic opioid therapy. J Affect Disord. 2017;211:136–43. 15; doi:https://doi.org/10.1016/j.jad.2016.12.052.
- Martins SS, Fenton MC, Keyes KM, Blanco C, Zhu H, Storr CL. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2012;42(6):1261–72. doi:https://doi.org/10.1017/S0033291711002145.
- Schuckit MA, Smith TL, Kalmijn JA. The patterns of drug and alcohol use and associated problems over 30 years in 397 men. Alcohol Clin Exp Res. 2014;38(1):227–34. doi:https://doi.org/10.1111/acer.12220.
- Gariepy G, Honkaniemi H, Quesnel-Vallee A. Social support and protection from depression: systematic review of current findings in Western countries. Br J Psychiatry. 2016;209(4):284–93. doi:https://doi.org/10.1192/bjp.bp.115.169094.
- American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders (DSM-5®). Washington, DC: American Psychiatric Publishing.
- Teicher M, Glod C, Cole J. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry. 1990;147(2):207–10. doi:https://doi.org/10.1176/ajp.147.2.207.
- Silverstone PH, Williams R, McMahon L, Fleming R, Fogarty S. Alcohol significantly lowers the seizure threshold in mice when co-administered with bupropion hydrochloride. Ann Gen Psychiatry. 2008;7(1):11–5. doi:https://doi.org/10.1186/1744-859X-7-11.
- Kang SG, Park YM, Lee HJ, Yoon B. Duloxetine-induced liver injury in patients with major depressive disorder. Psychiatry Investig. 2011;8(3):269–71. doi:https://doi.org/10.4306/pi.2011.8.3.269.
- Dundon W, Lynch KG, Pettinati HM, Lipkin C. Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy. Alcohol: Clin Exp Res. 2004;28:1065–73.
- Nunes EV, Sullivan MA, Levin FR. Treatment of depression in patients with opiate dependence. Biol Psychiatry. 2004;56(10):793–802. doi:https://doi.org/10.1016/j.biopsych.2004.06.037.